« Graphical Crankiness |
| Off the Beaten Track. Way, Way, Off. »
April 26, 2011
AstraZeneca Tears 'Em Down
Well, this takes things along another step - AstraZeneca has looked over its Wilmington-area site, which has a lot of empty space in it now, and decided that the best thing to do is: start tearing buildings down:
AstraZeneca will demolish 450,000 square feet of laboratory space in three buildings at its North American headquarters campus off Concord Pike in Fairfax as part of its global restructuring, the drug giant has confirmed.
The three buildings account for a major chunk of the company's Fairfax campus and house all of the company's Delaware-based research efforts. The huge complex west of Concord Pike is only about a decade old.
But as this article clarifies, the buildings that are coming down are generally 30 years old and more. In this climate, leasing them out to someone else is probably almost impossible, even if it were physically feasible. And it's not easy to turn a lab building into much of anything else. So what else to do? I hate to see this, but I can't come up with a better answer, either.
The first research site I worked at (Schering-Plough in Bloomfield, NJ) was torn down, after repeated attempts to find a buyer for it in the early 1990s. A Home Depot (and its parking lot) occupies the space now. That one was an even harder sell, with cramped and still older buildings, and in the end, the company couldn't even give the place away. But this is a sad thing to see, no matter what.
+ TrackBacks (0) | Category: Business and Markets
POST A COMMENT
- RELATED ENTRIES
- The Worst Seminar
- Conference in Basel
- Messed-Up Clinical Studies: A First-Hand Report
- Pharma and Ebola
- Lilly Steps In for AstraZeneca's Secretase Inhibitor
- Update on Alnylam (And the Direction of Things to Come)
- There Must Have Been Multiple Chances to Catch This
- Weirdly, Tramadol Is Not a Natural Product After All